Clinical Features, DYT1 Mutation Screening and Genotype-Phenotype Correlation in Patients with Dystonia from Iran

被引:6
作者
Akbari, Mohammad Taghi [2 ]
Zand, Zahra [1 ]
Shahidi, Gholam Ali [3 ]
Hamid, Mohammad [1 ]
机构
[1] Pasteur Inst Iran, Biotechnol Res Ctr, Div Mol Med, Tehran 13164, Iran
[2] Tarbiat Modares Univ, Fac Med Sci, Dept Med Genet, Tehran, Iran
[3] Iran Univ Med Sci, Hazrat Rasool Hosp, Dept Neurol, Tehran, Iran
基金
美国国家科学基金会;
关键词
Primary dystonia; Clinical features; DYT1; gene; GAG deletion; PRIMARY TORSION DYSTONIA; GAG DELETION; IDIOPATHIC DYSTONIA; GENE; ONSET; FREQUENCY; DIAGNOSIS; GERMANY; PROTEIN;
D O I
10.1159/000336783
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To test Iranian patients with primary torsion dystonia to determine the frequency of 904-906 del GAG mutation in the DYT1 (TOR1A) gene and to investigate the genotype-phenotype association for this disease. Subjects and Methods: Sixty-three patients with primary dystonia were investigated. DNA was extracted from peripheral blood and these samples were subjected to PCR-sequencing for exon 5 of the DYT1 gene. Results: Of the 63 patients, 10 (15.9%) carried the triplet GAG deletion mutation; this is a high DYT1-positive rate in comparison with other populations and the type of dystonia in this positive group was generalized in all except 1. In our patients, limbs were the most severely involved site at the time of onset and in most cases it developed to generalized form. The majority of DYT1-positive cases showed higher leg onset (5 patients, 62.5%) in comparison with higher arm onset in negative patients (20 patients, 50%). Also, the progression to generalized dystonia in DYT1-positive patients was significantly higher than in DYT1-negative patients. The mean age at onset was 8.6 +/- 1.6 years (7-12 years) in DYT1-positive patients, while mean age at onset in patients with no GAG deletion mutation was higher (15.7 +/- 11.5 years). Conclusions: The DYT1 904-906 del GAG mutation is responsible for some of Iranian dystonia patients, and screening for the DYT1 deletion is significant in cases with the generalized type of primary dystonia. Also, patients with leg or arm onset at a younger age are more likely to be DYT1-positive among primary torsion dystonia cases. Copyright (c) 2012 S. Karger AG, Basel
引用
收藏
页码:462 / 466
页数:5
相关论文
共 30 条
[1]   Classification and genetics of dystonia [J].
Aguiar, PMD ;
Ozelius, LJ .
LANCET NEUROLOGY, 2002, 1 (05) :316-325
[2]   Sequence Analysis of blaCTX-M Genes Carried by Clinically Significant Escherichia coli Isolates in Kuwait Hospitals [J].
Al Hashem, G. ;
Al Sweih, N. ;
Jamal, W. ;
Rotimi, V. O. .
MEDICAL PRINCIPLES AND PRACTICE, 2011, 20 (03) :213-219
[3]   A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes:: report of an EFNS/MDS-ES Task Force [J].
Albanese, A. ;
Barnes, M. P. ;
Bhatia, K. P. ;
Fernandez-Alvarez, E. ;
Filippini, G. ;
Gasser, T. ;
Krauss, J. K. ;
Newton, A. ;
Rektor, I. ;
Savoiardo, M. ;
Valls-Sole, J. .
EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 (05) :433-444
[4]   IDIOPATHIC DYSTONIA AMONG ASHKENAZI JEWS - EVIDENCE FOR AUTOSOMAL DOMINANT INHERITANCE [J].
BRESSMAN, SB ;
DELEON, D ;
BRIN, MF ;
RISCH, N ;
BURKE, RE ;
GREENE, PE ;
SHALE, H ;
FAHN, S .
ANNALS OF NEUROLOGY, 1989, 26 (05) :612-620
[5]   Clinical and genetic evaluation in a french population presenting with primary focal dystonia [J].
Dhaenens, CM ;
Krystkowiak, P ;
Douay, X ;
Charpentier, P ;
Bele, S ;
Destée, A ;
Sablonnière, B .
MOVEMENT DISORDERS, 2005, 20 (07) :822-825
[6]  
Fahn S, 1998, Adv Neurol, V78, P1
[7]  
Fahn S MC., 1987, Movement Disorders, V2, P332
[8]   The AAA plus protein torsinA interacts with a conserved domain present in LAP1 and a novel ER protein [J].
Goodchild, RE ;
Dauer, WT .
JOURNAL OF CELL BIOLOGY, 2005, 168 (06) :855-862
[9]   Frequency and phenotypic variability of the GAG deletion of the DYT1 gene in an unselected group of patients with dystonia [J].
Grundmann, K ;
Laubis-Hermann, U ;
Bauer, I ;
Dressler, D ;
Vollmer-Haase, J ;
Bauer, P ;
Stuhrmann, M ;
Schulte, T ;
Schöls, L ;
Topka, H ;
Riess, O .
ARCHIVES OF NEUROLOGY, 2003, 60 (09) :1266-1270
[10]   EFNS guidelines on the molecular diagnosis of neurogenetic disorders: general issues, Huntington's disease, Parkinson's disease and dystonias [J].
Harbo, H. F. ;
Finsterer, J. ;
Baets, J. ;
Van Broeckhoven, C. ;
Di Donato, S. ;
Fontaine, B. ;
De Jonghe, P. ;
Lossos, A. ;
Lynch, T. ;
Mariotti, C. ;
Schoels, L. ;
Spinazzola, A. ;
Szolnoki, Z. ;
Tabrizi, S. J. ;
Tallaksen, C. ;
Zeviani, M. ;
Burgunder, J. -M. ;
Gasser, T. .
EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (07) :777-785